Acide pamidronique [INN-French] en es it fr

Acide pamidronique [INN-French] Brand names, Acide pamidronique [INN-French] Analogs

Acide pamidronique [INN-French] Brand Names Mixture

  • No information avaliable

Acide pamidronique [INN-French] Chemical_Formula

C3H11NO7P2

Acide pamidronique [INN-French] RX_link

http://www.rxlist.com/cgi/generic/aredia.htm

Acide pamidronique [INN-French] fda sheet

Acide_pamidronique_[INN-French] FDA

Acide pamidronique [INN-French] msds (material safety sheet)

Acide_pamidronique_[INN-French] MSDS

Acide pamidronique [INN-French] Synthesis Reference

No information avaliable

Acide pamidronique [INN-French] Molecular Weight

235.07 g/mol

Acide pamidronique [INN-French] Melting Point

No information avaliable

Acide pamidronique [INN-French] H2O Solubility

No information avaliable

Acide pamidronique [INN-French] State

No information avaliable

Acide pamidronique [INN-French] LogP

-3.048

Acide pamidronique [INN-French] Dosage Forms

Liquid; Powder for solution; Solution

Acide pamidronique [INN-French] Indication

For the treatment of moderate or severe hypercalcemia associated with malignancy

Acide pamidronique [INN-French] Pharmacology

Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels of calcium in the blood associated with malignancy (cancer); and to reduce the breakdown of bone due to metastases of breast cancer or multiple myeloma.

Acide pamidronique [INN-French] Absorption

No information avaliable

Acide pamidronique [INN-French] side effects and Toxicity

Side effects include an allergic reaction, kidney problems, seizures, low levels of calcium, magnesium, or phosphorus in the blood

Acide pamidronique [INN-French] Patient Information

No information avaliable

Acide pamidronique [INN-French] Organisms Affected

Humans and other mammals